The Latest Breaking News from Nasdaq

  Stoke Therapeutics (NASDAQ:STOK) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Stoke Therapeutics reported an EPS of $-0.66.

Global E Online (NASDAQ:GLBE) has observed the following analyst ratings within the last quarter:

Hanover Bancorp, Inc. (NASDAQ:HNVR) IPO will take place May, 11 on the NASDAQ exchange under the ticker HNVR. The company is offering shares at an expected price between $21.00 and $23.00 per share with an insider lock-up period of 180 days ending on November 07, 2022.

Wytec International, Inc (NASDAQ:WYTC) IPO will take place May, 11 on the NASDAQ exchange under the ticker WYTC. The company is offering shares at an expected price of $4.25 per share with an insider lock-up period of 180 days ending on November 07, 2022.

Pulled from Benzinga Pro data, Henry Schein (NASDAQ:HSIC) posted Q1 earnings of $186.00 million, an increase from Q4 of 22.25%. Sales dropped to $3.18 billion, a 4.56% decrease between quarters.

Zealand Pharma A/S (NASDAQ:ZEAL) has amended its existing financing agreement with Oberland Capital Management LLC, under which Zealand will repurchase $50 million of note principal with a 1.2x prepayment premium. Oberland Capital will provide Zealand with up to $75.0 million in incremental capital, of which $50.0 million is to be reserved for M&A…

Pulled from Benzinga Pro data, Itron (NASDAQ:ITRI) posted Q1 earnings of $896.00 thousand, an increase from Q4 of 101.53%. Sales dropped to $475.33 million, a 2.12% decrease between quarters.

According to Benzinga Pro, during Q1, Credit Acceptance (NASDAQ:CACC) earned $214.30 million, a 1.52% increase from the preceding quarter. Credit Acceptance's sales decreased to $455.70 million, a 1.62% change since Q4.

Pulled from Benzinga Pro data, Cardlytics (NASDAQ:CDLX) posted Q1 earnings of $33.04 million, an increase from Q4 of 379.16%. Sales dropped to $67.93 million, a 24.57% decrease between quarters.